| Serial Number | 85732596 |
| Word Mark | DGANTA |
| Filing Date | Wednesday, September 19, 2012 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, June 20, 2016 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 19, 2013 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | (Based on Intent to Use) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives; (Based on 44(d) Priority Application) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives |
| Translation of Words in Mark | The wording "DGANTA" has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 22, 2012 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Basel CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Basel CH |
| Event Date | Event Description |
| Monday, June 20, 2016 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Monday, June 20, 2016 | ABANDONMENT - NO USE STATEMENT FILED |
| Thursday, November 19, 2015 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, November 18, 2015 | EXTENSION 5 GRANTED |
| Wednesday, November 11, 2015 | EXTENSION 5 FILED |
| Wednesday, November 11, 2015 | TEAS EXTENSION RECEIVED |
| Tuesday, May 26, 2015 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Saturday, May 23, 2015 | EXTENSION 4 GRANTED |
| Tuesday, May 12, 2015 | EXTENSION 4 FILED |
| Tuesday, May 12, 2015 | TEAS EXTENSION RECEIVED |
| Friday, November 14, 2014 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 13, 2014 | EXTENSION 3 GRANTED |
| Monday, November 10, 2014 | EXTENSION 3 FILED |
| Monday, November 10, 2014 | TEAS EXTENSION RECEIVED |
| Thursday, May 15, 2014 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 14, 2014 | EXTENSION 2 GRANTED |
| Thursday, April 24, 2014 | EXTENSION 2 FILED |
| Tuesday, May 13, 2014 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, April 24, 2014 | TEAS EXTENSION RECEIVED |
| Saturday, November 9, 2013 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 7, 2013 | EXTENSION 1 GRANTED |
| Thursday, November 7, 2013 | EXTENSION 1 FILED |
| Thursday, November 7, 2013 | TEAS EXTENSION RECEIVED |
| Tuesday, May 14, 2013 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 19, 2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 19, 2013 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 27, 2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, February 11, 2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, February 11, 2013 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, February 11, 2013 | DATA MODIFICATION COMPLETED |
| Monday, February 11, 2013 | ASSIGNED TO LIE |
| Thursday, January 31, 2013 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 30, 2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 30, 2013 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, January 16, 2013 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, January 16, 2013 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, January 16, 2013 | SUSPENSION LETTER WRITTEN |
| Wednesday, January 16, 2013 | ASSIGNED TO EXAMINER |
| Saturday, September 22, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, September 22, 2012 | NEW APPLICATION ENTERED IN TRAM |